Business
Paradigm (ASX:PAR) share price shoots 30% higher on FDA update
Image source: Getty Images
The Paradigm Biopharmaceuticals Ltd (ASX: PAR) share price has returned from its trading halt and is charging higher on Wednesday.
At the time of writing, the biopharmaceutical company’s shares are up 30% to $2.69.
Why is the Paradigm share price charging higher?
…
Continue Reading
